lumineux glutathione Built on the science Size:Pack of 4 ZAVI.SKIN Products BPC-157 & TB-500 Blend
BPC-157 & TB-500 Blend | Research Peptide Ireland — Pure Peptides Direct
Disclosure of interest: Nothing to disclose Poster Session I - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.02 - SECONDARY PREVENTION P412 - ESOC25-2081 THE CURRENT STATUS, DECISION MAKING AND EFFECTIVENESS OF DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ISCHEMIC STROKE IN CHINA Xiaoqing Jiang 1 , Zixiao Li 1,2,3 , Yongjun Wang 1,2,3 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 2 China National Clinical Research Center for Neurological Diseases, Beijing, China, 3 National Center for Healthcare Quality Management in Neurological Diseases, Beijing, China Background and Aims: In real-world settings, the application scope of dual antiplatelet therapy (DAPT) for acute ischemic stroke (AIS) is more extensive than that of randomized controlled trials (RCTs)
ZAVI.SKIN Products
Size:Pack of 4
Because actin plays a central role in tissue structure, TB-500 helps researchers study cellular organization and regeneration signaling
Built on the science of smile longevity.